Literature DB >> 23490250

Hemodynamics and arteriovenous malformations in cavopulmonary anastomosis: the case for residual antegrade pulsatile flow.

Roland Henaine1, Mathieu Vergnat, Olaf Mercier, Alain Serraf, Vincent De Montpreville, Jean Ninet, Emile A Bacha.   

Abstract

OBJECTIVES: Continuous flow in Fontan circulation results in impairment of pulmonary artery endothelial function, increased pulmonary vascular resistance, and, potentially, late failure of Fontan circulation. Bidirectional cavopulmonary shunt is the interim procedure in palliation of patients with single-ventricle physiology, but pulmonary arteriovenous malformations occur in many patients. In a porcine chronic model of cavopulmonary shunt, we studied pulmonary hemodynamics, pulmonary arteriovenous malformation occurrence, and gas exchange capabilities. We hypothesized that residual antegrade pulsatile pulmonary flow may attenuate the deleterious effects of nonpulsatile Fontan-type circulation.
METHODS: Thirty pigs underwent a sham procedure (n = 10, group I), a cavopulmonary shunt with right pulmonary artery ligation (n = 10, group II, nonpulsatile), or a cavopulmonary shunt with proximal right pulmonary artery partial ligation (n = 10, group III, micropulsatile). Three months later, in vivo hemodynamics, blood gas exchange, pulmonary arteriovenous malformation occurrence, and lung histology were assessed.
RESULTS: At 3 months, group II right lungs demonstrated significantly increased pulmonary artery pressure, pulmonary vascular resistance, and evidence of pulmonary arteriovenous malformations compared with groups I and III (all P < .001). Group III lungs also showed increased pulmonary artery pressure and pulmonary vascular resistance compared with the sham group, but significantly less than group II. Group III right lungs had the best gas exchange performance, with less histologic changes compared with group II.
CONCLUSIONS: We developed a viable chronic large animal model of bidirectional cavopulmonary anastomosis. Residual antegrade pulsatile flow in the setting of a cavopulmonary shunt prevents pulmonary arteriovenous malformation formation and attenuates, but does not suppress, the development of pulmonary hypertension. From a clinical standpoint, these data would support keeping a small amount of antegrade pulsatile flow during creation of a cavopulmonary shunt.
Copyright © 2013 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  11.3; 17; 20; 9; CPS; Fio(2); PA; PAP; PVP; PVR; Pco(2); Po(2); SVC; Sao(2); arterial oxyhemoglobin saturation; cavopulmonary shunt; inspired oxygen fraction; partial pressure of carbon dioxide; partial pressure of oxygen; pulmonary artery; pulmonary artery pressure; pulmonary vascular resistance; pulmonary vein pressure; superior vena cava

Mesh:

Year:  2013        PMID: 23490250     DOI: 10.1016/j.jtcvs.2013.02.036

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  9 in total

Review 1.  Pulmonary arteriovenous malformations after the superior cavopulmonary shunt: mechanisms and clinical implications.

Authors:  Minoo N Kavarana; Jeffrey A Jones; Robert E Stroud; Scott M Bradley; John S Ikonomidis; Rupak Mukherjee
Journal:  Expert Rev Cardiovasc Ther       Date:  2014-04-23

2.  Pulmonary vascular disease in a failed Fontan patient with Down's syndrome.

Authors:  Masaya Aoki; Keiichi Hirono; Tomonori Higuma; Yoko Suzuki; Kazuhiko Nakayama; Akio Yamashita; Kazuaki Fukahara; Fukiko Ichida; Noriaki Emoto; Naoki Yoshimura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-08-10

3.  Pulmonary arteriovenous malformations in a patient with single ventricle and polysplenia syndrome.

Authors:  Shinichiro Sakaki; Taiyu Hayashi; Hiroshi Ono
Journal:  BMJ Case Rep       Date:  2019-07-02

Review 4.  Decision-Making for Surgery in the Management of Patients with Univentricular Heart.

Authors:  Ryan Robert Davies; Christian Pizarro
Journal:  Front Pediatr       Date:  2015-07-27       Impact factor: 3.418

Review 5.  Is the Hepatic Factor a miRNA that Maintains the Integrity of Pulmonary Microvasculature by Inhibiting the Vascular Endothelial Growth Factor?

Authors:  Joseph J Vettukattil
Journal:  Curr Cardiol Rev       Date:  2017

6.  A potential future Fontan modification: preliminary in vitro data of a pressure-generating tube from engineered heart tissue.

Authors:  Maria Köhne; Charlotta Sophie Behrens; Tim Stüdemann; Constantin von Bibra; Eva Querdel; Aya Shibamiya; Birgit Geertz; Jakob Olfe; Ida Hüners; Stefan Jockenhövel; Michael Hübler; Thomas Eschenhagen; Jörg Siegmar Sachweh; Florian Weinberger; Daniel Biermann
Journal:  Eur J Cardiothorac Surg       Date:  2022-07-11       Impact factor: 4.534

7.  Pulmonary Arteriovenous Fistulae After Fontan Operation: Incidence, Clinical Characteristics, and Impact on All-Cause Mortality.

Authors:  Hideo Ohuchi; Aki Mori; Michikazu Nakai; Kazuto Fujimoto; Toru Iwasa; Heima Sakaguchi; Kenichi Kurosaki; Isao Shiraishi
Journal:  Front Pediatr       Date:  2022-06-09       Impact factor: 3.569

8.  Pulmonary Vasodilator Therapy in Children with Single Ventricle Physiology: Effects on Saturation and Pulmonary Arterial Pressure.

Authors:  Ida Jeremiasen; Karin Tran-Lundmark; Nikmah Idris; Phan-Kiet Tran; Shahin Moledina
Journal:  Pediatr Cardiol       Date:  2020-07-30       Impact factor: 1.655

9.  Proceedings From the 2019 Stanford Single Ventricle Scientific Summit: Advancing Science for Single Ventricle Patients: From Discovery to Clinical Applications.

Authors:  Sushma Reddy; Stephanie Siehr Handler; Sean Wu; Marlene Rabinovitch; Gail Wright
Journal:  J Am Heart Assoc       Date:  2020-03-19       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.